| Harinarayan Balasubramanian, MD | |
|
5401 Old Court Rd, Randallstown, MD 21133-5103 | |
| (410) 521-2200 | |
| Not Available |
| Full Name | Harinarayan Balasubramanian |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 36 Years |
| Location | 5401 Old Court Rd, Randallstown, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124064787 | NPI | - | NPPES |
| 408943000 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | D0063648 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Union Hospital Of Cecil County | Elkton, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North American Partners In Anesthesia Maryland Llc | 1850283144 | 77 |
News Archive
Transcept Pharmaceuticals Inc. has received the Food and Drug Administration (FDA) approval for its drug Intermezzo - a drug that can help people get back to sleep after waking in the middle of the night. The treatment contains a low-dose of zolpidem tartrate, the active ingredient in Paris-based Sanofi's sleeping pill Ambien.
The Department of Health and Human Services denied requests from Kansas and Oklahoma to allow them to adjust the health law's medical-loss ratio provisions. That brings to eight the number of states who will not receive such exemptions.
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
New Phase III data published today in "Current Medical Research and Opinion" highlight that the recommended starting dose of 2 mg of LIVALO (pitavastatin), a novel synthetic statin, was statistically superior to simvastatin at a dose of 20 mg over 12 weeks in reducing low-density lipoprotein cholesterol
› Verified 1 days ago
| Entity Name | Union Hospital Of Cecil County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124067848 PECOS PAC ID: 6901719822 Enrollment ID: O20040121001109 |
News Archive
Transcept Pharmaceuticals Inc. has received the Food and Drug Administration (FDA) approval for its drug Intermezzo - a drug that can help people get back to sleep after waking in the middle of the night. The treatment contains a low-dose of zolpidem tartrate, the active ingredient in Paris-based Sanofi's sleeping pill Ambien.
The Department of Health and Human Services denied requests from Kansas and Oklahoma to allow them to adjust the health law's medical-loss ratio provisions. That brings to eight the number of states who will not receive such exemptions.
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
New Phase III data published today in "Current Medical Research and Opinion" highlight that the recommended starting dose of 2 mg of LIVALO (pitavastatin), a novel synthetic statin, was statistically superior to simvastatin at a dose of 20 mg over 12 weeks in reducing low-density lipoprotein cholesterol
› Verified 1 days ago
| Entity Name | North American Partners In Anesthesia Maryland Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093707879 PECOS PAC ID: 1850283144 Enrollment ID: O20040330000405 |
News Archive
Transcept Pharmaceuticals Inc. has received the Food and Drug Administration (FDA) approval for its drug Intermezzo - a drug that can help people get back to sleep after waking in the middle of the night. The treatment contains a low-dose of zolpidem tartrate, the active ingredient in Paris-based Sanofi's sleeping pill Ambien.
The Department of Health and Human Services denied requests from Kansas and Oklahoma to allow them to adjust the health law's medical-loss ratio provisions. That brings to eight the number of states who will not receive such exemptions.
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
New Phase III data published today in "Current Medical Research and Opinion" highlight that the recommended starting dose of 2 mg of LIVALO (pitavastatin), a novel synthetic statin, was statistically superior to simvastatin at a dose of 20 mg over 12 weeks in reducing low-density lipoprotein cholesterol
› Verified 1 days ago
| Entity Name | Cumberland Anesthesia Ams Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033531785 PECOS PAC ID: 4981825056 Enrollment ID: O20141015001480 |
News Archive
Transcept Pharmaceuticals Inc. has received the Food and Drug Administration (FDA) approval for its drug Intermezzo - a drug that can help people get back to sleep after waking in the middle of the night. The treatment contains a low-dose of zolpidem tartrate, the active ingredient in Paris-based Sanofi's sleeping pill Ambien.
The Department of Health and Human Services denied requests from Kansas and Oklahoma to allow them to adjust the health law's medical-loss ratio provisions. That brings to eight the number of states who will not receive such exemptions.
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
New Phase III data published today in "Current Medical Research and Opinion" highlight that the recommended starting dose of 2 mg of LIVALO (pitavastatin), a novel synthetic statin, was statistically superior to simvastatin at a dose of 20 mg over 12 weeks in reducing low-density lipoprotein cholesterol
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Harinarayan Balasubramanian, MD 11781 Lee Jackson Memorial Hwy, Suite 550, Fairfax, VA 22033-3309 Ph: (571) 777-5157 | Harinarayan Balasubramanian, MD 5401 Old Court Rd, Randallstown, MD 21133-5103 Ph: (410) 521-2200 |
News Archive
Transcept Pharmaceuticals Inc. has received the Food and Drug Administration (FDA) approval for its drug Intermezzo - a drug that can help people get back to sleep after waking in the middle of the night. The treatment contains a low-dose of zolpidem tartrate, the active ingredient in Paris-based Sanofi's sleeping pill Ambien.
The Department of Health and Human Services denied requests from Kansas and Oklahoma to allow them to adjust the health law's medical-loss ratio provisions. That brings to eight the number of states who will not receive such exemptions.
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
New Phase III data published today in "Current Medical Research and Opinion" highlight that the recommended starting dose of 2 mg of LIVALO (pitavastatin), a novel synthetic statin, was statistically superior to simvastatin at a dose of 20 mg over 12 weeks in reducing low-density lipoprotein cholesterol
› Verified 1 days ago
Jon A Newsome, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5401 Old Court Rd, Randallstown, MD 21133 Phone: 410-521-2200 | |
Nicholas Patchan, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5401 Old Court Rd, Randallstown, MD 21133 Phone: 410-521-2200 | |
Dr. Francesca Marie Uberoi, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 5401 Old Court Rd, Lifebridge Anesthesia Llc, Randallstown, MD 21133 Phone: 410-701-4547 Fax: 417-701-4342 | |
Michael Bezman, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5401 Old Court Rd, Randallstown, MD 21133 Phone: 410-521-2200 | |
Harinath Meda, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5401 Old Court Rd, Randallstown, MD 21133 Phone: 410-701-4547 Fax: 410-701-4342 | |
Wallace Kowalczyk, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5401 Old Court Rd, Randallstown, MD 21133 Phone: 410-521-2200 Fax: 410-655-7190 |